D. Yao

发表

Ang-2 promotes lung cancer metastasis by increasing epithelial-mesenchymal transition

Z. Dong, Jianrong Chen, Xuli Yang, 2018, Oncotarget.

Alteration of oncogenic IGF-II gene methylation status associates with hepatocyte malignant transformation.

Z. Dong, Wenjie Zheng, Li Wang, 2019, Hepatobiliary & pancreatic diseases international : HBPD INT.

Role of secretory clusterin in hepatocarcinogenesis.

Z. Dong, Wenjie Zheng, M. Fang, 2018, Translational gastroenterology and hepatology.

Diagnostic Values and Molecular-targeted of Oncofetal Glypican-3 for Hepatocellular Carcinoma

Z. Dong, Li Wang, M. Yao, 2016 .

Advances in the study of oncofetal antigen glypican-3 expression in HBV-related hepatocellular carcinoma.

Z. Dong, Wenjie Zheng, Li Wang, 2016, Bioscience trends.

Oncogenic secretory clusterin in hepatocellular carcinoma: Expression at early staging and emerging molecular target.

Wei Wu, Z. Dong, Wenjie Zheng, 2017, Oncotarget.

Expression of oncofetal antigen glypican-3 associates significantly with poor prognosis in HBV-related hepatocellular carcinoma

Z. Dong, Li Wang, M. Yao, 2016, Oncotarget.

Abnormality of Wnt3a expression as novel specific biomarker for diagnosis and differentiation of hepatocellular carcinoma

Wei Wu, Xuli Yang, Wenjie Zheng, 2016, Tumor Biology.

Glypican-3 as an emerging molecular target for hepatocellular carcinoma gene therapy

Z. Dong, Wenjie Zheng, Li Wang, 2014, Tumor Biology.

Targeted glypican-3 gene transcription inhibited the proliferation of human hepatoma cells by specific short hairpin RNA

Wei Wu, Z. Dong, M. Yao, 2012, Tumor Biology.

Secretory clusterin promotes hepatocellular carcinoma progression by facilitating cancer stem cell properties via AKT/GSK-3β/β-catenin axis

Wenjie Zheng, Li Wang, Mengna Wu, 2020, Journal of Translational Medicine.

Expression of Src Suppressed C Kinase Substrate in Rat Neural Tissues During Inflammation

Meijuan Yan, Shunxing Zhu, Jianmei Zhao, 2014, Neurochemical Research.

Expression Characteristics of Hypoxia-Inducible Factor-1α and Its Clinical Values in Diagnosis and Prognosis of Hepatocellular Carcinoma

Q. Ni, Wei Wu, Li Wang, 2011, Hepatitis monthly.

Mechanism of Hypoxia-Inducible Factor-1alpha Over- Expression and Molecular-Target Therapy for Hepatocellular Carcinoma

Z. Dong, M. Yao, D. Yao, 2011 .

Characteristics of hepatic igf-ii expression and monitored levels of circulating igf-ii mRNA in metastasis of hepatocellular carcinoma.

Wei Wu, Zhiwei Wang, G. Shi, 2010, American journal of clinical pathology.

Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma.

Wei Wu, Jian-hua Zhu, Z. Dong, 2005, World journal of gastroenterology.

Chapter 13 Insulin-Like Growth Factor-II : Molecular-Targeted Therapy for Hepatocellular Carcinoma

Li Wang, M. Yao, D. Yao, 2017 .

Novel Mechanism of Nonalcoholic Lipid Accumulation Promoting Malignant Transformation of Hepatocytes

Z. Dong, Wenjie Zheng, Li Wang, 2018, Neoplasm.

Nonalcoholic Lipid Accumulation and Hepatocyte Malignant Transformation

D. Yao, Xuli Yang, Li Wang, 2016, Journal of clinical and translational hepatology.

IGF-I receptor as an emerging potential molecular-targeted for hepatocellular carcinoma in vitro and in vivo

Li Wang, M. Yao, D. Yao, 2016, Tumor Biology.

Secretory Clusterin AS A Novel Molecular-targeted for Inhibiting Hepatocellular Carcinoma Growth.

Z. Dong, Wenjie Zheng, Li Wang, 2020, Current medicinal chemistry.

Oncogenic Wnt3a: A Candidate Specific Marker and Novel Molecular Target for Hepatocellular Carcinoma

Z. Dong, Wenjie Zheng, Li Wang, 2019, Journal of Cancer.

Oncogenic Wnt3a: a promising specific biomarker in hepatocellular carcinoma

Wenjie Zheng, M. Fang, M. Yao, 2018, Hepatoma Research.

Study on correlation between hepatic fibrosis and fat indexes in patients with NAFLD and Type 2 diabetes mellitus

M. Yao, D. Yao, Jiajia Shi, 2020 .

Bezafibrate upregulates carnitine palmitoyltransferase II expression and promotes mitochondrial energy crisis dissipation in fibroblasts of patients with influenza-associated encephalopathy.

H. Kido, D. Yao, J. Chida, 2011, Molecular genetics and metabolism.

Diagnostic and monitoring values of circulating AFP-mRNA and HS-GGT for hepatocellular carcinoma *

Yao Yao, Li Wang, M. Yao, 2014 .

Clinical Impact of Plasma TGF-β1 and Circulating TGF-β1 mRNA in Diagnosis of Hepatocellular Carcinoma

Wei Wu, Z. Dong, M. Yao, 2008 .

Abnormal Expression of Hepatic Transforming Growth Factor-β1 at the Early Stage of Hepatocellular Carcinoma Formation

Wei Wu, Hua Huang, Z. Dong, 2008 .

Identification of m6A- and ferroptosis-related lncRNA signature for predicting immune efficacy in hepatocellular carcinoma

Hongjun Xie, M. Yao, D. Yao, 2022, Frontiers in Immunology.

The application of bio-nanotechnology in tumor diagnosis and treatment: a view

M. Yao, D. Yao, Jingyuan Li, 2018 .

Intervention of NF-κB activation inhibits the growth of human hepatocellular carcinoma HepG2 cells

Wei Wu, D. Yao, N. Yao, 2010 .

Suppression of human hepatoma (HepG2) cell growth by nuclear factor-kappaB/p65 specific siRNA

Wei Wu, Zhiwei Wang, D. Yao, 2010, Tumor Biology.

Silencing clusterin gene transcription on effects of multidrug resistance reversing of human hepatoma HepG2/ADM cells

Yao Yao, Wenjie Zheng, M. Yao, 2015, Tumor Biology.

Mitochondrial carnitine palmitoyl transferase-II inactivity aggravates lipid accumulation in rat hepatocarcinogenesis

Wenjie Zheng, Li Wang, M. Yao, 2017, World journal of gastroenterology.

Abnormal expressions of inflammatory-related mediators and inhibition of fat metabolism in mice infected with influenza a virus.

D. Yao, Li Wang, M. Yao, 2015, Pakistan journal of pharmaceutical sciences.